Statements (55)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:Company
|
gptkbp:acquisition |
various international pharmaceutical companies
|
gptkbp:awards |
gptkb:National_Quality_Award
Top 100 Pharmaceutical Companies in China |
gptkbp:category |
gptkb:traditional_Chinese_medicine
medical devices biological products chemical drugs |
gptkbp:CEO |
gptkb:Zhang_Jian
|
gptkbp:certifications |
ISO certification
GMP_certification |
gptkbp:clinicalTrials |
various drug candidates
|
gptkbp:collaborations |
hospitals
academic institutions research organizations healthcare_providers |
gptkbp:community_engagement |
educational initiatives
local health programs |
gptkbp:community_outreach |
health fairs
screening programs health education workshops |
gptkbp:employees |
over 10,000
|
gptkbp:exportMarkets |
gptkb:Asia
gptkb:North_America Europe |
gptkbp:financialPerformance |
dividend payments
strong market presence consistent growth |
gptkbp:founded |
1994
|
gptkbp:future_plans |
expansion into new markets
development of new therapies increased R&D investment |
gptkbp:headquarters |
gptkb:Harbin,_China
|
https://www.w3.org/2000/01/rdf-schema#label |
Harbin Pharmaceutical Group
|
gptkbp:industry |
pharmaceuticals
|
gptkbp:investmentFocus |
biotechnology startups
|
gptkbp:market |
gptkb:China
|
gptkbp:partnerships |
global pharmaceutical firms
|
gptkbp:patentCitation |
numerous pharmaceutical patents
|
gptkbp:products |
medications
|
gptkbp:research_focus |
oncology
neurological disorders cardiovascular diseases infectious diseases |
gptkbp:researchAndDevelopment |
biopharmaceuticals
|
gptkbp:revenue |
over 1 billion USD
|
gptkbp:social_responsibility |
environmental sustainability programs
healthcare_initiatives |
gptkbp:stockExchange |
gptkb:Shenzhen_Stock_Exchange
000663 |
gptkbp:subsidiary |
gptkb:Harbin_Pharmaceutical_Group_Co.,_Ltd.
|
gptkbp:sustainability_initiatives |
energy efficiency projects
waste reduction programs green manufacturing practices |
gptkbp:website |
www.hbpharm.com
|